Trials / Completed
CompletedNCT00386009
Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multicenter Study to Evaluate the Urodynamic Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Male
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the function of the bladder and urethra during urinary storage or voiding in men with signs and symptoms of benign prostatic hyperplasia treated with either placebo or tadalafil.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tadalafil | 20 mg tadalafil tablet taken by mouth once a day for 12 weeks. |
| DRUG | Placebo | Placebo tablet taken by mouth once a day for 12 weeks. |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2006-10-11
- Last updated
- 2009-07-09
- Results posted
- 2009-06-23
Locations
13 sites across 3 countries: United States, Greece, Portugal
Source: ClinicalTrials.gov record NCT00386009. Inclusion in this directory is not an endorsement.